Impact of a Plant-Based Diet on Indices of Cardiovascular Health in African Americans

April 28, 2022 updated by: Matthew Brothers, The University of Texas at Arlington

The Impact of a Plant-Based Diet on Indices of Cardiovascular Health in African Americans: A Cross-Sectional Study

The role of diet in preventing hypertension and cardiovascular diseases in African Americans, who have a much higher risk of developing these diseases, is not well understood. Therefore, this project will investigate whether African Americans following a 100% plant-based diet have more optimal blood pressure, vascular function, and blood lipid profiles, along with lower systemic inflammation relative to African Americans following a typical American diet.

Study Overview

Study Type

Observational

Enrollment (Actual)

19

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Arlington, Texas, United States, 76019
        • UT Arlington - Science and Engineering Innovation and Research Building

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Community sample from the greater Dallas-Fort Worth Metroplex area.

Description

Inclusion Criteria:

  • Self-identify as African American/Black
  • Self-reported adherence to either a typical American diet (not following a specific diet pattern) or 100% plant-based (vegan) diet
  • Age 18-40

Exclusion Criteria:

  • History of smoking within 2 years or being a current smoker
  • Taking vasoactive medications
  • Having overt cardiovascular, metabolic, or neurological disease
  • Pregnant individuals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Typical American Diet
African American individuals who self-report adhering to a typical American diet prior to enrolling in the study.
Participants self-reported adherence to a typical American diet prior to enrolling in the study. This factor determined cross-sectional group allocation.
Plant-Based Diet
African American individuals who self-report adhering to a plant-based diet prior to enrolling in the study.
Participants self-reported adherence to a 100% plant-based diet prior to enrolling in the study. This factor determined cross-sectional group allocation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG)
Time Frame: Day 1
Day 1
C-reactive protein
Time Frame: Day 1
Day 1
Post-occlusive brachial artery flow-mediated dilation (% change in brachial artery diameter from resting baseline)
Time Frame: Day 1
Day 1
Post-occlusive forearm reactive hyperemia (% change in brachial artery blood velocity from resting baseline)
Time Frame: Day 1
Day 1
Pulse wave velocity (carotid-to-femoral)
Time Frame: Day 1
Day 1
Augmentation index (AIx@HR75)
Time Frame: Day 1
Day 1
Cerebral vascular reactivity (% change in cerebrovascular conductance index from resting baseline)
Time Frame: Day 2
Day 2
Local cutaneous thermal hyperemia (% change in cutaneous vascular conductance from resting baseline)
Time Frame: Day 2
Day 2
Peripheral blood pressure (systolic, diastolic, mean)
Time Frame: Day 1
Day 1
Central blood pressure (systolic, diastolic, mean)
Time Frame: Day 1
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert M Brothers, PhD, The University of Texas at Arlington

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 12, 2019

Primary Completion (Actual)

January 13, 2020

Study Completion (Actual)

January 13, 2020

Study Registration Dates

First Submitted

April 12, 2022

First Submitted That Met QC Criteria

April 19, 2022

First Posted (Actual)

April 25, 2022

Study Record Updates

Last Update Posted (Actual)

May 5, 2022

Last Update Submitted That Met QC Criteria

April 28, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data Availability Statement: All raw data were collected and generated at the University of Texas at Arlington. Data supporting the findings and conclusions of this study are available from the corresponding author upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe